| |
Company
Roster
|
|
Total
Insiders : |
20 |
|
|
|
Total
Direct Shares :
|
16,255,169 |
|
|
Total
Indirect Shares :
|
1,503,239 |
| |
%
Held by Insiders:
|
15.68% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Merrigan Paul J |
|
|
0 |
|
0 |
| Muth David D |
EVP, Chief Commercial Officer |
2015-05-01 |
44,700 |
|
0 |
| O'keeffe Charles B |
Director |
2024-02-15 |
685,724 |
|
0 |
| Tierney David S |
Director |
2024-04-08 |
348,874 |
|
0 |
| Weinstein Jack |
V.P., Treasurer & CFO |
2010-12-20 |
14,493 |
2007-08-14 |
0 |
| Biomarin Pharmaceutical Inc |
10% Owner |
2012-12-08 |
6,666,667 |
2012-12-08 |
0 |
| Winship M Douglas |
VP, Regulatory Operations |
2015-11-04 |
134,131 |
2008-01-01 |
0 |
| Grande Alicia |
VP, Treasurer and CFO |
2023-12-27 |
55,813 |
2008-01-01 |
0 |
| Sundaram Preethi |
Chief Strategy Officer |
2024-02-15 |
25,541 |
2022-09-15 |
0 |
| Ingenito Gary |
Chief Med. & Reg. Officer |
2024-02-15 |
51,391 |
2019-11-20 |
0 |
| Del Carmen Jeffrey |
Chief Commercial Officer |
2024-02-15 |
25,968 |
2021-06-24 |
0 |
| Miller Steve |
Chief Op. & Scientific Officer |
2024-02-15 |
825,124 |
2008-01-01 |
0 |
| Daly Richard J |
President and CEO, Director |
2024-02-15 |
212,147 |
2020-12-22 |
0 |
| Denkhaus Donald A |
Director |
2024-02-15 |
438,333 |
2015-03-27 |
0 |
| Harper Molly |
Director |
2024-02-15 |
5,333 |
2023-02-15 |
0 |
| Elsbernd Brian |
Chief Compliance/Legal Officer |
2024-03-27 |
124,433 |
2020-12-22 |
0 |
| Coelho Philip H |
Director |
2023-05-04 |
204,887 |
2012-11-15 |
24,000 |
| Wallace Milton J |
Director |
2012-05-29 |
539,184 |
2010-03-04 |
29,184 |
| Mcenany Patrick J |
Chairman of Board of Directors, Director |
2024-01-30 |
4,528,256 |
2014-05-21 |
145,921 |
| Huckel Hubert E Md |
Director |
2014-10-02 |
1,324,170 |
2012-05-24 |
1,304,134 |
|
|
0.09 (0.55%) 
